
SN · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total Revenue | $6.40B | $5.53B | $4.25B | $3.72B | $3.73B |
| Cost of Revenue | $3.26B | $2.87B | $2.35B | $2.31B | $2.29B |
| Gross Profit | $3.14B | $2.66B | $1.91B | $1.41B | $1.44B |
| Research & Development | $368.07M | $341.29M | $249.39M | $215.66M | $200.64M |
| Selling, General & Administrative | $390.11M | $433.39M | $387.32M | $251.21M | $180.12M |
| Operating Expenses | $2.22B | $2.02B | $1.53B | $1.09B | $999.93M |
| Operating Income | $920.28M | $644.16M | $373.56M | $321.37M | $438.26M |
| Other Income / (Expense) | $28.60M | -$7.98M | -$35.43M | $7.63M | -$7.64M |
| Income Before Taxes | $900.28M | $572.47M | $293.23M | $301.98M | $414.33M |
| Provision for Income Taxes | $198.90M | $133.76M | $126.15M | $69.63M | $83.21M |
| Net Income | $701.40M | $438.70M | $167.10M | $232.35M | $331.11M |
| Basic EPS | $4.97 | $3.14 | $1.20 | $1.67 | $2.38 |
| Diluted EPS | $4.94 | $3.11 | $1.20 | $1.67 | $2.38 |
| Basic Shares Outstanding | 140.98M | 139.94M | 139.03M | 138.98M | 138.98M |
| Diluted Shares Outstanding | 142.09M | 141.08M | 139.42M | 138.98M | 138.98M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $5.89 | $5.87 | $5.95 | 5 | ↑3 ↓0 |
| Dec 2027 | $7.15 | $6.81 | $7.56 | 5 | ↑3 ↓0 |
| Dec 2028 | $9.14 | $9.14 | $9.14 | 1 | ↑0 ↓0 |